30% Fixed Returns Over 24 Months

The company are focused on the cultivation and production of medical cannabis. The company is aiming to deliver industry-leading healthcare solutions that demonstrate measurable excellence and value. The company boast the largest cultivation facility in Europe and the Northern hemisphere, with their primary aim being to help people live healthier lives.

• 30% return over 24 months. 12% year one, 18% year two.
• Board of Directors are leading industry experts for medicinal cannabis.
• 95 hectare facility, producing 700,000kgs Comparison site with a market capacity of $9.28bn, the current market leader. 
• The investment is Brexit proof.

The Rise of the Medical Cannabis Market

Europe's population is more than twice the size of the US and Canada combined, suggesting the potential for a considerably larger market. 

With public favour swinging in support of medical cannabis, pressure is being put on local authorities and governments to utilise medical cannabis treatments. As the UK joins a number of countries to legalise cannabis for medical use, we believe it is imminent that we will see full support across Europe.

It is estimated that, in ten years, the medical cannabis market will be worth €55.2bn. Cannabis is becoming one of the worlds fastest and most profitable industries for investors to enter into.

Investing in Portugal

In July 2018, legislation was signed into law to allow for the medical use of cannabis in Portugal and its dispensation at pharmacies. 

Only a few countries in Europe have the perfect climate for cannabis cultivation, with Portugal having favourable microclimatic conditions for cannabis cultivation. Together with reduced labour costs, the company identified Portugal as the primary place for its large scale facility.